Anika Therapeutics reported $354.12M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
Agenus AGEN:US $ 456.17M 14.87M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Anika Therapeutics ANIK:US $ 354.12M 11.88M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Chemocentryx CCXI:US $ 419.39M 21.06M
Clovis Oncology CLVS:US $ 392.86M 58.67M
Enanta Pharmaceuticals ENTA:US $ 385.21M 21.6M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Immunogen IMGN:US $ 422.3M 59.41M
Insmed INSM:US $ 1.05B 99.96M
Integra Lifesciences IART:US $ 3752.86M 80.86M
Intrexon XON:US $ 321.22M 14.34M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Macrogenics MGNX:US $ 218.04M 53.4M
Merit Medical Systems MMSI:US $ 1631.52M 1.78M
Peregrine Pharmaceuticals PPHM:US $ 429.84M 115.75M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Stryker SYK:US $ 36032M 105M
Surmodics SRDX:US $ 175.65M 8.54M
Veracyte VCYT:US $ 1144.2M 29.39M
Xencor XNCR:US $ 851.32M 6.6M
Zimmer Biomet Holdings Inc ZBH:US $ 21.45B 164.8M